Inhibition of HGF/cMET expression prevents distant recurrence of rectal cancer after preoperative chemoradiotherapy

International Journal of Oncology

Volumn 40, Issue 2, 2012, Pages 583-591

  Saigusa, Susumu ^a   Toiyama, Yuji ^a   Tanaka, Koji ^a   Yokoe, Takeshi ^a   Fujikawa, Hiroyuki ^a   Matsushita, Kohei ^a   Okugawa, Yoshinaga ^a   Inoue, Yasuhiro ^a   Uchida, Keiichi ^a   Mohri, Yasuhiko ^a   Kusunoki, Masato ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

cMET; Distant recurrence; Hepatocyte growth factor; Preoperative chemoradiotherapy; Rectal cancer

Indexed keywords

FLUOROURACIL; N (3 CHLOROPHENYL) 3 [3,5 DIMETHYL 4 (4 METHYL 1 PIPERAZINYLCARBONYL) 1H PYRROL 2 YLMETHYLENE] 2,3 DIHYDRO N METHYL 2 OXO 1H INDOLE 5 SULFONAMIDE; RNA; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; TEGAFUR;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RECURRENCE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISTANT METASTASIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MICRODISSECTION; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RECTUM CANCER; SIGNAL TRANSDUCTION; STROMA CELL; UPREGULATION;

ADENOCARCINOMA; ADULT; AGED; ANTIBODIES; CELL LINE, TUMOR; CELL PROLIFERATION; CHEMORADIOTHERAPY, ADJUVANT; FEMALE; GENE EXPRESSION; HEPATOCYTE GROWTH FACTOR; HUMANS; INDOLES; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; PIPERAZINES; PREOPERATIVE CARE; PROGNOSIS; RECEPTOR PROTEIN-TYROSINE KINASES; RECTAL NEOPLASMS; ROC CURVE; SULFONAMIDES;

EID: 84862907880     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1200     Document Type: Article

References (43)

1. Sauer R, Becker H, Hohenberger W, et al: Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351: 1731-1740, 2004.
2. Bosset JF, Collette L, Calais G, et al: Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355: 1114-1123, 2006. (Pubitemid 44394918)
3. Guillem JG, Chessin DB, Cohen AM, et al: Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer. Ann Surg 241: 829-838, 2005. (Pubitemid 40604929)
4. Camphausen K, Moses MA, Beecken WD, et al: Radiation therapy to a primary tumor accelerates metastatic growth in mice. Cancer Res 61: 2207-2211, 2001. (Pubitemid 32692049)
5. Wild-Bode C, Weller M, Rimner A, et al: Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma. Cancer Res 61: 2744-2750, 2001. (Pubitemid 32685864)
6. Schweigerer L, Rave-Frank M, Schmidberger H, et al: Sublethal irradiation promotes invasiveness of neuroblastoma cells. Biochem Biophys Res Commun 330: 982-988, 2005. (Pubitemid 40462182)
7. Qian LW, Mizumoto K, Inadome N, et al: Radiation stimulates HGF receptor/c-Met expression that leads to amplifying cellular response to HGF stimulation via upregulated receptor tyrosine phosphorylation and MAP kinase activity in pancreatic cancer cells. Int J Cancer 104: 542-549, 2003. (Pubitemid 36337253)
8. Sheng-Hua C, Yan-Bin M, Zhi-An Z, et al: Radiation-enhanced hepatocyte growth factor secretion in malignant glioma cell lines. Surg Neurol 68: 610-614, 2007.
9. Andarawewa KL, Erickson AC, Chou WS, et al: Ionizing radiation predisposes nonmalignant human mammary epithelial cells to undergo transforming growth factor beta induced epithelial to mesenchymal transition. Cancer Res 67: 8662-8670, 2007. (Pubitemid 47439813)
10. Jung JW, Hwang SY, Hwang JS, et al: Ionising radiation induces changes associated with epithelial-mesenchymal transdifferentiation and increased cell motility of A549 lung epithelial cells. Eur J Cancer 43: 1214-1224, 2007.
11. Tsukamoto H, Shibata K, Kajiyama H, et al: Irradiation-induced epithelial-mesenchymal transition (EMT) related to invasive potential in endometrial carcinoma cells. Gynecol Oncol 107: 500-504, 2007. (Pubitemid 350160864)
12. Fan S, Ma YX, Wang JA, et al: The cytokine hepatocyte growth factor/scatter factor inhibits apoptosis and enhances DNA repair by a common mechanism involving signaling through phosphatidyl inositol 3′ kinase. Oncogene 19: 2212-2223, 2000. (Pubitemid 30307187)
13. Xiao GH, Jeffers M, Bellacosa A, et al: Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways. Proc Natl Acad Sci USA 98: 247-252, 2001. (Pubitemid 32095895)
14. You WK and McDonald DM: The hepatocyte growth factor/c-Met signaling pathway as a therapeutic target to inhibit angiogenesis. BMB Rep 41: 833-839, 2008.
15. Sattler M and Salgia R: c-Met and hepatocyte growth factor: potential as novel targets in cancer therapy. Curr Oncol Rep 9: 102-108, 2007. (Pubitemid 46332381)
16. Herynk MH, Stoeltzing O, Reinmuth N, et al: Down-regulation of c-Met inhibits growth in the liver of human colorectal carcinoma cells. Cancer Res 63: 2990-2996, 2003. (Pubitemid 36667174)
17. Matsumoto K and Nakamura T: Hepatocyte growth factor and the Met system as a mediator of tumor-stromal interactions. Int J Cancer 119: 477-483, 2006. (Pubitemid 43955698)
18. Navab R, Liu J, Seiden-Long I, et al: Co-overexpression of Met and hepatocyte growth factor promotes systemic metastasis in NCI-H460 non-small cell lung carcinoma cells. Neoplasia 11: 1292-1300, 2009.
19. Grant DS, Kleinman HK, Goldberg ID, et al: Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci USA 90: 1937-1941, 1993. (Pubitemid 23069972)
20. Otte JM, Schmitz F, Kiehne K, et al: Functional expression of HGF and its receptor in human colorectal cancer. Digestion 61: 237-246, 2000. (Pubitemid 30418224)
21. Bussolino F, Di Renzo MF, Ziche M, et al: Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 119: 629-641, 1992.
22. Takeuchi H, Bilchik A, Saha S, et al: c-MET expression level in primary colon cancer: a predictor of tumor invasion and lymph node metastases. Clin Cancer Res 9: 1480-1488, 2003. (Pubitemid 36418405)
23. Boccaccio C and Comoglio PM: Invasive growth: a MET-driven genetic programme for cancer and stem cells. Nat Rev Cancer 6: 637-645, 2006. (Pubitemid 44140861)
24. Nakamura T, Matsumoto K, Kiritoshi A, et al: Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumorstromal interactions. Cancer Res 57: 3305-3313, 1997. (Pubitemid 27351751)
25. Jiang WG: Hepatocyte growth factor and the hepatocyte growth factor receptor signalling complex as targets in cancer therapies. Curr Oncol 14: 66-69, 2007.
26. Trusolino L and Comoglio PM: Scatter-factor and semaphorin receptors: cell signalling for invasive growth. Nat Rev Cancer 2: 289-300, 2002. (Pubitemid 37328782)
27. Eder JP, Vande Woude GF, Boerner SA, et al: Novel therapeutic inhibitors of the c-Met signaling pathway in cancer. Clin Cancer Res 15: 2207-2214, 2009.
28. Underiner TL, Herbertz T and Miknyoczki SJ: Discovery of Small Molecule c-Met Inhibitors: Evolution and profiles of clinical candidates. Anticancer Agents Med Chem 16: 7-27, 2009.
29. Berthou S, Aebersold DM, Schmidt LS, et al: The Met kinase inhibitor SU11274 exhibits a selective inhibition pattern toward different receptor mutated variants. Oncogene 23: 5387-5393, 2004. (Pubitemid 39005814)
30. Yoshikawa R, Kusunoki M, Yanagi H, et al: Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy. Cancer Res 61: 1029-1037, 2001. (Pubitemid 32174421)
31. Japanese Society for Cancer of the Colon and Rectum: General Rules for Clinical and Pathological Studies on Cancer of the colon, Rectum, and Anus. 7th edition. Kanehara & Co, Tokyo, 2006.
32. Saigusa S, Tanaka K, Toiyama Y, et al: Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy. Ann Surg Oncol 16: 3488-3498, 2009.
33. Bijwaard KE, Aguilera NS, Monczak Y, et al: Quantitative real-time reverse transcription-PCR assay for cyclin D1 expression: utility in the diagnosis of mantle cell lymphoma. Clin Chem 47: 195-201, 2001. (Pubitemid 32142916)
34. Sattler M, Pride YB, Ma P, et al: A novel small molecule met inhibitor induces apoptosis in cells transformed by the oncogenic TPR-MET tyrosine kinase. Cancer Res 63: 5462-5469, 2003. (Pubitemid 37139865)
35. Wang X, Le P, Liang C, et al: Potent and selective inhibitors of the Met [hepatocyte growth factor/scatter factor (HGF/SF) receptor] tyrosine kinase block HGF/SF-induced tumor cell growth and invasion. Mol Cancer Ther 2: 1085-1092, 2003.
36. Yokoe T, Toiyama Y, Okugawa Y, et al: KAP1 is associated with peritoneal carcinomatosis in gastric cancer. Ann Surg Oncol 17: 821-828, 2010.
37. Kammula US, Kuntz EJ, Francone TD, et al: Molecular co-expression of the c-Met oncogene and hepatocyte growth factor in primary colon cancer predicts tumor stage and clinical outcome. Cancer Lett 248: 219-228, 2007. (Pubitemid 46330555)
38. Toiyama Y, Miki C, Inoue Y, et al: Serum hepatocyte growth factor as a prognostic marker for stage II or III colorectal cancer patients. Int J Cancer 125: 1657-1662, 2009. (Pubitemid 44441370)
39. Ostman A: PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma. Cytokine Growth Factor Rev 15: 275-286, 2004.
40. Mueller MM and Fusenig NE: Friends or foes - bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 4: 839-849, 2004. (Pubitemid 39472951)
41. Tamura M, Arakaki N, Tsubouchi H, et al: Enhancement of human hepatocyte growth factor production by interleukin-1 alpha and -1 beta and tumor necrosis factor-alpha by fibroblasts in culture. J Biol Chem 268: 8140-8145, 1993. (Pubitemid 23120397)
42. Tse JC and Kalluri R: Mechanisms of metastasis: epithelial-to-mesenchymal transition and contribution of tumor microenvironment. J Cell Biochem 101: 816-829, 2007. (Pubitemid 47040864)
43. Bhowmick NA and Moses HL: Tumor-stroma interactions. Curr Opin Genet Dev 15: 97-101, 2005. (Pubitemid 40127637)